health
STAT+: A turning point for pancreatic cancer patients
Why this matters: health reporting relevant to everyday decisions and well-being.
Want to stay on top of the science and politics driving biotech today?&#x A0;Sign up&#x A0;to get our biotech newsletter in your inbox. We’re catching up on plenty of ASCO news from over the weekend, including detailed daraxonrasib results in pancreatic cancer, and a Chinese lung cancer therapy that continues to outperform expectations. Also, a decades-old peptide beloved by biohackers has become a lightning rod&#x A0;in a battle over FDA regulation of these substances.Continue to STAT+ to read the full story…
Article preview — originally published by STAT News. Full story at the source.
Read full story on STAT News →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from STAT News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop